INMUNE BIO INC. (INMB) Operating income 2017–2025
INMUNE BIO INC. (INMB) annual operating income history from SEC filings — each fiscal year as reported.
-$47.4MFY2025 · since FY2017: -$981,480 → -$47.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.4M | -11.1% |
| FY2024 | -$42.6M | -43.4% |
| FY2023 | -$29.7M | -14.6% |
| FY2022 | -$26.0M | +11.0% |
| FY2021 | -$29.2M | -138.4% |
| FY2020 | -$12.2M | -57.7% |
| FY2019 | -$7.8M | +37.7% |
| FY2018 | -$12.4M | -1167.5% |
| FY2017 | -$981,480 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INMB financial trends
INMB RevenueINMB Net incomeINMB Net marginINMB Gross profitINMB Gross marginINMB Operating marginINMB Operating cash flowINMB Free cash flowINMB Capital expendituresINMB Return on equityINMB Stock buybacksINMB Dividends paidINMB Total assetsINMB Total liabilitiesINMB Shareholders’ equityINMB overview →